All analyses
AI analysis

HNB Life PLC: research report

Moderately undervaluedbullishOct 5, 2026

Evidence points bullish: first-half life premium and reported profit grew 43%, reinforcing a moderately undervalued starting point. The catch is P/B is more expensive than 95% of days since 2019.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why bullish

  • Life gross written premium rose 43% in the first half, while reported profit after tax reached LKR 434 million.
  • June-quarter net profit rose 47.9% year-on-year, ahead of 23.9% revenue growth.
  • Return on equity was 18.6% for the twelve months to June 2026, supporting a P/B above the sector median.

Against this. At 1.6 times book value, the shares are more expensive than 95% of trading days since January 2019.

Net margin
1.6%sector 1.4%
from 3.2% a year earlier, revenue +23.9%
Return on equity
17.8%
twelve months to Sep 30, 2026, unaudited
P/E
8.7sector 15.6
earnings Rs 15.73 per share, year to Sep 2026
P/B
1.54sector 1.46
book Rs 88.20 per share
Dividend yield
3.67%sector 1.83%
31.8% of earnings paid out

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Oct 5, 2026. Sector figures are the median of 11 listed companies in the same sector.

Overview

HNB Life operates life and general insurance businesses in Sri Lanka, distributed through agency, bancassurance and alternate channels. The central change is faster premium growth feeding through to higher reported earnings, while the company continues to invest in digital processes and its general-insurance platform.

Price performance

At LKR 141 on 2 October 2026, the share had fallen 8.2% over three months against a 6.3% decline in the ASPI, so it lagged the market over that window. It remained 16.7% higher over six months while the ASPI fell 2.8%, showing that the recent retreat followed a stronger medium-term run.

The price stood 75.5% of the way from its 52-week low to high, leaving it nearer the top of its annual range than the bottom. The three-year record includes two falls of 15% or more, the deepest 23%, which took six months to recover; these are the scale and duration of prior retreats, not price levels.

Liquidity is limited: median daily turnover was LKR 1.3 million, and a LKR 1 million order is about 80% of what trades on a typical day, a large part of a day's trading.

Valuation

The P/E is 8.6 times, meaning LKR 8.60 is paid for every LKR 1 of trailing profit, and sits at the cheaper end of the insurance sector with a 25th-percentile ranking. The P/B is 1.6 times, or LKR 1.60 for each LKR 1 of net assets, above the sector median of 1.35; the twelve-month return on equity of 18.6% helps explain why the shares command a premium to book.

The company is inexpensive relative to sector earnings multiples but expensive against its own record: P/E is more expensive than 85% of days since January 2019 and P/B more expensive than 95%. At this price, the trailing P/E relies only modestly on the latest quarter, which supplied 13.3% of trailing EPS; using its year-ago net margin would move the P/E only to 8.8 times.

The dividend yield is 3.6%, with the payout rising to LKR 5.00 in FY2025 from LKR 3.90 in FY2024. That distribution used 30.5% of trailing earnings, leaving dividend cover of 3.28 times, although the FY2025 dividend's ex-date has passed and a buyer today does not receive it.

News and sentiment

Direct coverage was normal, with three material articles in the past 90 days: one positive and two neutral. The key update, reported on 7 August, was first-half life gross written premium growth of 43% to LKR 12.3 billion and profit after tax of LKR 434 million.

Board and operating appointments at the general-insurance subsidiary were also reported, but their financial terms or earnings effects were not disclosed. The LKR 5.00 FY2025 dividend went ex on 31 March 2026 and has already passed.

Financials

The June 2026 quarter was stronger year-on-year: revenue rose 23.9% to LKR 9.1 billion, operating profit rose 43.8% to LKR 440 million and net profit rose 47.9% to LKR 323 million. Profit therefore grew faster than the reported revenue line, although other operating income of LKR 2.5 billion means the insurer earns materially outside that line.

Gross margin is not available for the latest June quarter or a like-for-like year-ago comparison. The revenue-based operating and net margins are not suitable measures here because other operating income exceeds a quarter of reported revenue; on total income, operating margin was 3.8% and net margin was 2.8%. The June net margin was among the weakest six of seven comparable June quarters, so the profit increase did not reflect an unusually high margin.

Below operating profit, LKR 117 million was absorbed by finance costs, tax and other items, leaving less than the operating result for shareholders. Equity attributable to owners was LKR 13.2 billion, with 150 million shares outstanding, unchanged from the latest balance sheet. The filed June-quarter figures are historical: the 7 August news report supersedes them for the first half, citing LKR 434 million of profit after tax.

Risks

The main balance-sheet risk is insurer leverage: total liabilities were 4.71 times equity at December 2025, up from 3.99 times a year earlier. For an insurer this includes policy and other liabilities as well as funding obligations, so it describes the scale of claims and contractual obligations supported by each rupee of equity.

Sector conditions add an investment and currency risk. As at 5 October 2026, Treasury bill yields had risen for a third week, affecting insurers' government-security portfolios, while the rupee had weakened to 330.00/80 per US dollar, raising local-currency costs where reinsurance or claims settlements are foreign-currency linked. The recent share-price record and limited turnover add a separate trading risk: a LKR 1 million transaction is a large part of a normal session.

Outlook

As at 5 October 2026, the next specific catalyst is the September 2026 interim filing, expected between 6 and 14 November. It will replace the June-quarter figures and show whether the premium and profit growth reported for the first half continued into the next quarter.

The available data cannot separate how much of future earnings will come from underwriting, investment income or the general-insurance subsidiary. Sector-wide movements in Treasury yields and the rupee remain relevant to that next result, but the backdrop does not establish a company-specific outcome.

About this report. Generated on Oct 5, 2026 from market data up to Oct 2, 2026, 3 material news articles over 90 days and financials to Jun 30, 2026, and scored 72 of 100 on value (moderately undervalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports